Physician profile
John A Manley
NPI 1427051804
$313.48
in general payments reported to CMS, 2019-2025
9 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.08 · 2023: $132 · 2024: $52.42 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287 · Education: $6.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.87 |
| Education | $6.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $100.25 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Renal - Chronic |
| Travere Therapeutics, INC. | $57.58 | 2024-2025 | Filspari |
| Vifor Pharma, INC. | $46.73 | 2023-2024 | Veltassa, Korsuva |
| Vantive US Healthcare LLC | $43.67 | 2025 | Renal - Pd |
| Amgen INC. | $37.85 | 2022-2025 | Tavneos |
| Nxstage Medical, INC. | $27.40 | 2023 | Nxstage System One |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Manley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.